Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
about
arrayMap: a reference resource for genomic copy number imbalances in human malignanciesGenomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsGenomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancerAstrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiologyComprehensive molecular portraits of human breast tumoursComplex landscapes of somatic rearrangement in human breast cancer genomes.MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancerEmerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialThe consequences of chromosomal aneuploidy on the transcriptome of cancer cellsThe gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosisRCP is a human breast cancer-promoting gene with Ras-activating functionIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsA systematic comparison of copy number alterations in four types of female cancerSNP microarray analyses reveal copy number alterations and progressive genome reorganization during tumor development in SVT/t driven mice breast cancerSelective genomic copy number imbalances and probability of recurrence in early-stage breast cancerInferring tumor progression from genomic heterogeneityFlexible and accurate detection of genomic copy-number changes from aCGH.BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataProgenetix: 12 years of oncogenomic data curation.Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data.Integrated analysis of copy number variation and genome-wide expression profiling in colorectal cancer tissuesSIRAC: Supervised Identification of Regions of Aberration in aCGH datasets.Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerComparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis.Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissuesComprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancerImproved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modulesExpression of the embryonic stem cell marker SOX2 in early-stage breast carcinomaDNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.
P2860
Q21134582-B53B14F6-65AA-4B26-B28E-01C73D66A002Q24595882-D5685C67-2209-4885-9BA8-C96E291D8F22Q24610167-59E95144-5B5A-4EF1-BF95-291EEEC96136Q24616987-43EE2C24-D5AF-4D42-B611-ABC6874915EBQ24630844-65DCF7D3-F851-4D4B-A76D-C2A841477320Q24631412-88121CBF-787B-4CD3-BD01-D1DEE400EE3FQ24651422-5BD53A4D-E9A6-4122-890A-DF840CA33ECCQ26766271-52F1DFCC-047E-418A-95CD-EFD3904383DCQ26782613-4EA3DF3F-8DED-4B09-8177-4491BEE2D067Q26995532-9C2A8A40-53CC-4436-BC10-3B8F09322A1CQ27322396-DF78677F-B909-403B-B279-7822F4840F1FQ27340316-EED4F3C8-A43B-4422-8F9E-31FC762B326EQ28252569-33AFFD48-207C-42FF-B68D-8690C75AECB1Q28302352-5DA0B4BE-6E81-4D80-9891-0C6F8DD3D3A5Q28394747-EAC72F1C-4B44-43DF-AAE0-0770F35351AAQ28710136-C7467E8C-5D30-4771-980B-6CBDB7E38D80Q28741460-096D2B48-40A0-45F4-A660-5D7D585319B9Q28749457-DE3A18C6-0E11-4872-B2E8-E64096369255Q30479616-D2CB1DBC-D8D5-4BF3-9A88-29CC41272516Q30497664-64A7C8D0-8539-492F-AE9F-86D536681539Q30587051-90D1A28C-23D7-4080-B1C4-35585BA2E334Q30694445-07DE9C60-41B0-425F-86DA-65B95FE24075Q31142505-C50CC816-A1E0-4D23-86ED-8B84226E0993Q31155184-81153EB3-117C-4F3B-8450-760F7D3213D0Q33304400-C6EAE29A-0B3C-4281-996D-474424C0750BQ33340988-B3881CFF-B4BA-4DD1-94C2-4FAAAA1CCF4EQ33358940-200DF66D-7747-4769-B7A0-F9FB9F6A8AFFQ33370712-01B1823E-91A9-4CFC-B937-877FDC6DFB6AQ33415281-2B2A3E6E-F1DE-481E-B725-E6E13A478700Q33416006-AECA738A-9905-4249-9F23-2BFC2C309A51Q33420154-79E8BD94-F63B-4787-9239-21199BB7930BQ33479152-4B6FAB04-E659-48AA-9B65-58AD6C090D59Q33523637-2FE0DDBB-9BF5-4397-B2D6-E7EEDE7AC194Q33627191-05D4F401-25AC-4A28-8E9E-E0A2D6184C42Q33670486-5286ABA0-7B6F-4B5D-9CAB-242ABAA944E9Q33687781-51039144-F379-47F0-A52B-24FB73FD8BD5Q33738285-81E3DB82-78EC-4CE3-9B09-A16A7E9FA224Q33806378-C79FF856-D5BC-40C3-872C-FFDCA3964548Q33816178-C38C23A9-734E-4B71-889D-5527C2AC7F16Q33826097-333B2CAB-5E7A-4FA8-B48E-4F1E6C6FFFD7
P2860
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@en
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@nl
type
label
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@en
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@nl
prefLabel
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@en
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@nl
P2093
P2860
P50
P356
P1476
Distinct patterns of DNA copy ...... ion subtypes of breast cancer.
@en
P2093
Tina Hernandez-Boussard
Young H Kim
P2860
P304
P356
10.1002/GCC.20366
P50
P577
2006-11-01T00:00:00Z